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Chromatin immunoprecipitation (ChIP) is the most widely
used method to study protein-DNA interactions. A suc-
cessful ChIP, however, is largely depending on the use of
well characterized, highly specific ChIP-grade antibodies.
ChIP-seq has become the gold standard for whole-gen-
ome mapping of protein-DNA interactions. The general-
ized adoption of this technology is currently limited by
four main technical hurdles. First, the reproducibility and
biological relevance of DNA-associated protein landscapes
depend on the specificity and performance of the antibo-
dies in the context for which they are used. Second, the
ChIP-seq method requires optimized protocols ensuring
high recovery and increased signal-to-noise ratio. Third, as
an effort to reduce the cost per sample and improve repro-
ducibility, the ChIP-seq method should be compatible
with automation. Finally, the economical and widespread
use of ChIP-seq requires access to a fast and high value/
quality next-generation sequencing platform. Here, we
demonstrate the successful use of the Diagenode inte-
grated line of products to establish a QC procedure to
qualify antibodies and standardize ChIP-seq experiments.
Author details
1Diagenode S.A., CHU, Tour GIGA B34, 3ème étage 1 Avenue de I’Hôpital,
4000 Liège, Sart-Tilman, Belgium. 2Diagenode Inc., 400 Morris Avenue, Suite
101, Denville, NJ 07834, USA.
Published: 8 April 2013
doi:10.1186/1756-8935-6-S1-P133
Cite this article as: Mazon et al.: Successful implementation of ChIP-seq
antibody quality control at Diagenode using automated ChIP protocol
on the SX-8G IP-Star® Compact. Epigentics & Chromatin 2013 6(Suppl 1):
P133.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit2Diagenode Inc., 400 Morris Avenue, Suite 101, Denville, NJ 07834, USA
Full list of author information is available at the end of the article
Mazon et al. Epigentics & Chromatin 2013, 6(Suppl 1):P133
http://www.epigeneticsandchromatin.com/content/6/S1/P133
© 2013 Mazon et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
